Platform
Consulting
Resources
Pricing
MEDTEQ+ — AVISÉ program - Quebec - Canada
Open
Closing Soon

MEDTEQ+ — AVISÉ program

Funding for validation and evaluation of innovative health technologies
Last Update: March 4, 2026
Funding available
$ 700,000
Timeline
  • Open Date : March 13, 2026
  • Closing date : April 10, 2026
Location
Quebec, Canada

Overview

The AVISÉ program provides non-repayable financial support of up to $700,000 to innovative Quebec-based life sciences companies for the real-world evaluation of new or significantly improved health technologies close to commercialization. Eligible activities include validation studies, collaboration with expert evaluation teams, and initiatives aimed at demonstrating the overall value and market readiness of health innovations.
/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Access new markets
Eligible Funding
  • Maximum amount : 700,000 $
  • Up to 50% of project cost
Timeline
  • Open Date : March 13, 2026
  • Closing date : April 10, 2026

Eligible candidates

Eligible Industries
  • Professional, scientific and technical services
  • Health care and social assistance
Location
  • Quebec
Legal structures
  • For-profit business
  • Social economy enterprise
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • Startups

Next steps

1
Determine your project
2
Validate your eligibility

Activities funded

  • Evaluation of a new product, technology, or process in the health or medical sector that is near commercialization.
  • Assessment of significant improvements to an existing product, technology, or process in healthcare, requiring research and development efforts.
  • Projects that demonstrate the overall value and relevance of a health technology to facilitate market access in Quebec, nationally, or internationally.
  • Studies conducted in collaboration with expert evaluation teams to test technologies addressing priority needs in areas such as primary care access, patient care pathways, task automation, or robotic surgery.
  • Initiatives aiming to validate the commercial potential of a new health innovation, subject to technological or business risk, within an 18-month timeline.

Eligibility

Who is eligible?

  • For-profit companies in the medical technology sector
  • For-profit companies in digital health technologies, including those using artificial intelligence
  • Social economy enterprises as defined by Quebec legislation

Who is not eligible

  • Companies listed on the Register of Enterprises Ineligible for Public Contracts (RENA), including subcontractors registered on RENA.
  • Companies listed on the non-compliance list for the francization process by the Office québécois de la langue française.
  • Companies that have defaulted on obligations related to previous government financial assistance within the last two years.
  • State-owned enterprises, companies controlled by government entities (municipal, provincial, or federal), municipal organizations, or companies majority-owned by a state enterprise.
  • Holding companies, companies under bankruptcy or insolvency protection, and companies whose main activity relates to arms production, fossil fuel extraction/production (excluding carbon transition), gambling, violent games or combat sports, sexual exploitation, or tobacco/drug-related business.

Eligible expenses

  • Direct labour costs dedicated to the project, including benefits and mandatory contributions.
  • Student scholarships.
  • Materials, consumables, and supplies required for the project.
  • Purchase or rental of equipment (up to a maximum of 25% of total eligible expenses).
  • Travel and accommodation expenses directly related to project execution, in accordance with government standards.
  • Professional fees for technology evaluation by expert evaluators.
  • Professional fees for the implementation and usage of the technology by evaluation sites.
  • Professional and specialized service fees, and subcontracting expenses.
  • Costs for disseminating project results.
  • Fees for specialized platforms.
  • Acquisition costs for studies or other documentation needed for the project.
  • Monetary compensation for participant involvement.
  • Project management fees charged by MEDTEQ+.
  • Indirect research costs (FIR) related to the project.

Eligible geographic areas

  • Quebec (companies must be registered in Quebec, have an establishment, and actively operate there)

Additional information

  • Applicants must ensure the inclusion of all required documents, such as signed forms and video presentations, for a complete application.
  • An online information session will be offered, with the recording subsequently available on the MEDTEQ+ website.
  • Evaluation committees may request a brief Q&A session with applicants whose proposals are considered eligible.
  • Annual follow-up reports on project outcomes are required one and two years after project completion.

Contacts

Frequently Asked Questions about the MEDTEQ+ — AVISÉ program Program

Here are answers to the most common questions about the MEDTEQ+ — AVISÉ program. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the MEDTEQ+ — AVISÉ program?

The AVISÉ program provides non-repayable financial support of up to $700,000 to innovative Quebec-based life sciences companies for the real-world evaluation of new or significantly improved health technologies close to commercialization. Eligible activities include validation studies, collaboration with expert evaluation teams, and initiatives aimed at demonstrating the overall value and market readiness of health innovations.

How much funding can be received?

MEDTEQ+ — AVISÉ program Funds up to 50% of admissible expenses, capped at $700,000 per project.

What is the deadline to apply?

The application deadline for this grant program is **April 10, 2026**. Applicants must submit their complete application before this date to be considered for funding.

Who is eligible for the MEDTEQ+ — AVISÉ program program?

To be eligible for the MEDTEQ+ — AVISÉ program program, you must: Legally constituted for-profit company in Quebec or Canada, registered and established in Quebec Active in medical technology or digital health sectors (including AI) Owns intellectual property rights for the product or innovation

What expenses are eligible under MEDTEQ+ — AVISÉ program?

Evaluation of a new product, technology, or process in the health or medical sector that is near commercialization. Assessment of significant improvements to an existing product, technology, or process in healthcare, requiring research and development efforts. Projects that demonstrate the overall value and relevance of a health technology to facilitate market access in Quebec, nationally, or internationally. Studies conducted in collaboration with expert evaluation teams to test technologies addressing priority needs in areas such as primary care access, patient care pathways, task automation, or robotic surgery. Initiatives aiming to validate the commercial potential of a new health innovation, subject to technological or business risk, within an 18-month timeline.

Who can I contact for more information about the MEDTEQ+ — AVISÉ program?

You can contact Consortium de recherche et d’innovation en technologies médicales du Québec by email at avise@medteq.ca.

Where is the MEDTEQ+ — AVISÉ program available?

The MEDTEQ+ — AVISÉ program program is available the province of Quebec.